A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)

Clinical trial NCT02127710 · COMPLETED

Trial details

NCT number: NCT02127710
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Papillary Renal Cell Cancer

Start date: 2014-04-30
Primary completion: 2016-04-14
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.